Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus

Scandinavian Journal of Rheumatology

Volumn 27, Issue 3, 1998, Pages 219-224

  Funauchi, M ^a   Ikoma, S ^a   Enomoto, H ^a   Horiuchi, A ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD4; Cytoplasmic cytokine; Monensin; SLE

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MONENSIN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKINS; IONOMYCIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MONENSIN; TETRADECANOYLPHORBOL ACETATE; TH1 CELLS; TH2 CELLS;

EID: 0031804643     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097498440859     Document Type: Article

References (26)

1. Mossman TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
2. Powrie F and Coffman R. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993;14:270-4.
3. Haanen JBAG, de Waal Malefyt R, Res PCM, Kraafman EM, Ottenhoff TEM, de Vries RRP, et al. Selection of a human T helper type 1-like T cell subset by Mycobacteria. J Exp Med 1991;174:583-92.
4. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin RL. Patterns of cytokine production by Mycobacterum-reactive human T-cell clone. Infect Immun 1993;61:197-203.
5. Romagnani S. Lymphokine production by human T cells in disease state. Ann Rev Immunol 1994;12:227-57.
6. Berton MT, Vitetta ES. Interleukin-4 induces changes in the chromatin structure of the Ig switch region in resting B cells before switch recombination. J Exp Med 1990;172:375-8.
7. Ichiki T, Takahasi W, Watanabe T. Regulation of the expression of human C germline transcript. J Immunol 1993;150:5408-17.
8. Albrecht B, Peiritsch S, Woisetschlager M. A bifunctional control element in the human IgE germline promotor involved in repression and IL-4 activation. Int Immunol 1994;6:1143-51.
9. Tsokos GC, Boumpas DT, Smith PL, et al. Deficient gamma-IFN production in patients with SLE. Arthritis Rheum 1988;29:1210-5.
10. Tsokos GC, Balow JE. Cellular immune responses in systemic lupus erythematosus. Prog Allergy 1984;35:93-161.
11. Chioazzi N. An overview of cellular immune function in systemic lupus erythematosus. In: Lahita RG ed. Systemic Lupus Erythematosus. New York: Churchill Livingstone, 1980:23-60.
12. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Horwitz DA. Detective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 1983;130:2651-5.
13. Ishida H, Kumagai S, Umehara H, Sano H, Tagaya Y, Yodoi J, et al. Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus. J Immunol 1987;139:1070-74.
14. Alcocer-Varela J, Alarcon-Segovia D. Decreased production of and response to interleukin 2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982;69:1388-94.
15. Barcellini W, Rizzardi GP, Borghi MO, Nicoretti F, Fain C, Del Papa N, et al. In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 1996;5:139-45.
16. Alcocer-Varela J, Alarcon-Segovia D. Longitudinal study on the production and cellular response to interleukin-2 in patients with systemic lupus erythematosus. Rheumatol Int 1995;15:57-63.
17. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993;14:335-8.
18. Sanders B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 1991;119:65-93.
19. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159:197-207.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Bombardier C, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
22. Richaud-Patin Y, Alcocer-Varela J, Llorente L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995;47:267-72.
23. Tanaka Y, Saito K, Shirakawa F, Ota T, Suzuki H, Eto S, et al. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 1988; 141:3043-9.
24. Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul WE. Role of NK1.1 + T cells in a Th2 response and in immunoglobulin E production. Science 1995;270:1845-7.
25. Hagiwara E, Gourley MF, Lee S, Klinman DK. Disease activity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379-85.
26. Bermas BL, Petri M, Goldman D, Mittleman B, Miller MW, Stocks NI, et al. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol 1994;14:169-77.